{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T10:27:54Z","timestamp":1786357674588,"version":"build-2736575974"},"reference-count":148,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T00:00:00Z","timestamp":1786147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008727","name":"Institute of Cardiology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008727","id-type":"DOI","asserted-by":"publisher"}]},{"id":[{"id":"https:\/\/ror.org\/04vs72b15","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Obstructive sleep apnea (OSA) affects nearly one billion adults worldwide and involves mechanical upper-airway obstruction alongside metabolic dysfunction, systemic inflammation, and gut\u2013brain axis disruption. Despite the efficacy of continuous positive airway pressure (CPAP), suboptimal long-term adherence highlights the need for complementary pharmacological strategies. This narrative review synthesizes preclinical and clinical evidence on GLP-1-based therapies, encompassing selective GLP-1 receptor agonists and tirzepatide, a dual GIP\/GLP-1 receptor agonist, in obesity-associated OSA. Preclinical studies show that GLP-1 receptor activation can reduce visceral adiposity, attenuate pro-inflammatory signaling, improve glucose and lipid metabolism, and modulate hypothalamic appetite circuits. However, the only identified murine study evaluating liraglutide during intermittent hypoxia\u2014an experimental model of one component of OSA rather than the complete disorder\u2014did not reverse hypoxia-induced insulin resistance, indicating that persistent intermittent hypoxia may limit metabolic improvement in that model. Clinically, liraglutide and tirzepatide have reduced the apnea\u2013hypopnea index (AHI) and improved several cardiometabolic outcomes. Numerically larger AHI reductions were reported in the tirzepatide trials, although no head-to-head comparison with selective GLP-1 receptor agonists is available. Tirzepatide is approved by the U.S. Food and Drug Administration for moderate-to-severe OSA in adults with obesity, together with a reduced-calorie diet and increased physical activity, and may be used without concomitant positive airway pressure in eligible patients or as an adjunct to ongoing therapy. The observed respiratory benefits appear to be mediated predominantly by weight loss and related reductions in mechanical and metabolic burden. Evidence supporting additional weight-independent mechanisms remains insufficient, and longer-term mechanistic studies in broader populations are required.<\/jats:p>","DOI":"10.3390\/ijms27167108","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T09:24:53Z","timestamp":1786353893000},"page":"7108","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["GLP-1 Receptor Agonists in Obstructive Sleep Apnea: A Translational Perspective on Mechanisms and Clinical Implications"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-3201-905X","authenticated-orcid":false,"given":"Isabella","family":"G\u00f3mez-Maldonado","sequence":"first","affiliation":[{"name":"Research Group in Applied Biomedical Sciences (UR Biomed), School of Medicine and Health Sciences, Universidad del Rosario, Bogota 111221, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5058-7624","authenticated-orcid":false,"given":"Andrea","family":"Rodr\u00edguez-Arana","sequence":"additional","affiliation":[{"name":"Research Group in Applied Biomedical Sciences (UR Biomed), School of Medicine and Health Sciences, Universidad del Rosario, Bogota 111221, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2577-5720","authenticated-orcid":false,"given":"Alejandro","family":"Tamayo-Pinz\u00f3n","sequence":"additional","affiliation":[{"name":"Research Group in Applied Biomedical Sciences (UR Biomed), School of Medicine and Health Sciences, Universidad del Rosario, Bogota 111221, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Esteban","family":"Albornoz-Su\u00e1rez","sequence":"additional","affiliation":[{"name":"Research Group in Applied Biomedical Sciences (UR Biomed), School of Medicine and Health Sciences, Universidad del Rosario, Bogota 111221, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jos\u00e9","family":"L\u00f3pez-Franco","sequence":"additional","affiliation":[{"name":"Research Group in Applied Biomedical Sciences (UR Biomed), School of Medicine and Health Sciences, Universidad del Rosario, Bogota 111221, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Andr\u00e9s","family":"Mejia-Manrique","sequence":"additional","affiliation":[{"name":"Research Group in Applied Biomedical Sciences (UR Biomed), School of Medicine and Health Sciences, Universidad del Rosario, Bogota 111221, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9867-4256","authenticated-orcid":false,"given":"Juan Jacobo","family":"Forero-Caycedo","sequence":"additional","affiliation":[{"name":"Research Group in Applied Biomedical Sciences (UR Biomed), School of Medicine and Health Sciences, Universidad del Rosario, Bogota 111221, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9989-6980","authenticated-orcid":false,"given":"Luis Carlos","family":"Rojas-Rodr\u00edguez","sequence":"additional","affiliation":[{"name":"Research Group in Applied Biomedical Sciences (UR Biomed), School of Medicine and Health Sciences, Universidad del Rosario, Bogota 111221, Colombia"},{"name":"Pharmacology Unit, Department of Biomedical Sciences, School of Medicine and Health Sciences, Universidad del Rosario, Bogota 111221, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2894-2203","authenticated-orcid":false,"given":"Natalia","family":"Buitrago-Ricaurte","sequence":"additional","affiliation":[{"name":"Neuroscience Research Group (NeURos), NeuroVitae Center for Neuroscience, School of Medicine and Health Sciences, Universidad del Rosario, Bogota 111221, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2282-066X","authenticated-orcid":false,"given":"Mariana","family":"Gaviria-Carrillo","sequence":"additional","affiliation":[{"name":"Neuroscience Research Group (NeURos), NeuroVitae Center for Neuroscience, School of Medicine and Health Sciences, Universidad del Rosario, Bogota 111221, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8100-7340","authenticated-orcid":false,"given":"Jes\u00fas","family":"Rodr\u00edguez-Quintana","sequence":"additional","affiliation":[{"name":"Fundaci\u00f3n CardioInfantil-Instituto de Cardiolog\u00eda, Bogota 111156, Colombia"},{"name":"Hospital Universitario Mayor Mederi, Bogota 111411, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7305-8727","authenticated-orcid":false,"given":"Carlos Alberto","family":"Calder\u00f3n-Ospina","sequence":"additional","affiliation":[{"name":"Research Group in Applied Biomedical Sciences (UR Biomed), School of Medicine and Health Sciences, Universidad del Rosario, Bogota 111221, Colombia"},{"name":"Pharmacology Unit, Department of Biomedical Sciences, School of Medicine and Health Sciences, Universidad del Rosario, Bogota 111221, Colombia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.arbres.2021.03.017","article-title":"Documento internacional de consenso sobre apnea obstructiva del sue\u00f1o","volume":"58","author":"Mediano","year":"2022","journal-title":"Arch. Bronconeumol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"597","DOI":"10.5664\/jcsm.2172","article-title":"Rules for Scoring Respiratory Events in Sleep: Update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events","volume":"8","author":"Berry","year":"2012","journal-title":"J. Clin. Sleep Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S2213-2600(19)30198-5","article-title":"Estimation of the global prevalence and burden of obstructive sleep apnoea: A literature-based analysis","volume":"7","author":"Benjafield","year":"2019","journal-title":"Lancet Respir. Med."},{"key":"ref_4","first-page":"33","article-title":"Prevalencia de apnea de sue\u00f1o en Colombia: Un an\u00e1lisis de las bases de datos del Ministerio de Salud","volume":"37","author":"Rosselli","year":"2024","journal-title":"Iatreia"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.15446\/revfacmed.v65n1Sup.60091","article-title":"Fisiopatolog\u00eda del s\u00edndrome de apnea-hipopnea obstructiva del sue\u00f1o (SAHOS)","volume":"65","author":"Garcia","year":"2017","journal-title":"Rev. Fac. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1513\/AnnalsATS.201702-181FR","article-title":"Role of Leptin in Obstructive Sleep Apnea","volume":"14","author":"Imayama","year":"2017","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_7","unstructured":"(2026, June 04). NCA\u2014Continuous Positive Airway Pressure (CPAP) Therapy for Obstructive Sleep Apnea (OSA) (CAG-00093R2)\u2014Decision Memo, Available online: https:\/\/www.cms.gov\/medicare-coverage-database\/view\/ncacal-decision-memo.aspx?proposed=N&NCAId=204."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1513\/pats.200707-114MG","article-title":"Pathophysiology of Adult Obstructive Sleep Apnea","volume":"5","author":"Eckert","year":"2008","journal-title":"Proc. Am. Thorac. Soc."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41392-023-01496-3","article-title":"Pathophysiological mechanisms and therapeutic approaches in obstructive sleep apnea syndrome","volume":"8","author":"Lv","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1702616","DOI":"10.1183\/13993003.02616-2017","article-title":"Challenges and perspectives in obstructive sleep apnoea: Report by an ad hoc working group of the Sleep Disordered Breathing Group of the European Respiratory Society and the European Sleep Research Society","volume":"52","author":"Randerath","year":"2018","journal-title":"Eur. Respir. J."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Joskin, A., and Bruyneel, M. (2024). Challenges in Obstructive Sleep Apnea Management in Elderly Patients. J. Clin. Med., 13.","DOI":"10.3390\/jcm13247718"},{"key":"ref_12","unstructured":"(2022). Obstructive Sleep Apnea. Handbook of Clinical Neurology, Elsevier. Available online: https:\/\/www.sciencedirect.com\/science\/chapter\/handbook\/abs\/pii\/B9780323915328000173."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/eer3.6","article-title":"Effect of pharyngeal wall compliance on passive collapsibility of retropalatal airway in patients with obstructive sleep apnea","volume":"1","author":"Tian","year":"2024","journal-title":"Eye ENT Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.17241\/smr.2020.00829","article-title":"Anatomy and Pathophysiology of Upper Airway Obstructive Sleep Apnoea: Review of the Current Literature","volume":"12","author":"Tan","year":"2021","journal-title":"Sleep Med. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"885","DOI":"10.2147\/NSS.S423303","article-title":"Characteristics and Mechanism of Upper Airway Collapse Revealed by Dynamic MRI During Natural Sleep in Patients with Severe Obstructive Sleep Apnea","volume":"15","author":"Li","year":"2023","journal-title":"Nat. Sci. Sleep"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2147\/NSS.S143296","article-title":"Sleeping tongue: Current perspectives of genioglossus control in healthy individuals and patients with obstructive sleep apnea","volume":"10","author":"Cori","year":"2018","journal-title":"Nat. Sci. Sleep"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1152\/japplphysiol.00083.2021","article-title":"Regional genioglossus reflex responses to negative pressure pulses in people with obstructive sleep apnea","volume":"133","author":"Carberry","year":"2022","journal-title":"J. Appl. Physiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"103362","DOI":"10.1016\/j.resp.2019.103362","article-title":"Relationship between the activity of the genioglossus, other peri-pharyngeal muscles and flow mechanics during wakefulness and sleep in patients with OSA and healthy subjects","volume":"274","author":"Oliven","year":"2020","journal-title":"Respir. Physiol. Neurobiol."},{"key":"ref_19","unstructured":"Dotan, Y., Pillar, G., and Oliven, A. (2026, June 05). Asynchrony of Lingual Muscle Recruitment During Sleep in Obstructive Sleep Apnea. Available online: https:\/\/journals.physiology.org\/doi\/epdf\/10.1152\/japplphysiol.00937.2014."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1152\/japplphysiol.00919.2009","article-title":"Obesity and upper airway control during sleep","volume":"108","author":"Schwartz","year":"2010","journal-title":"J. Appl. Physiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1183\/09031936.00047010","article-title":"Adipose tissue in obesity and obstructive sleep apnoea","volume":"39","author":"Bonsignore","year":"2012","journal-title":"Eur. Respir. J."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Deng, H., Duan, X., Huang, J., Zheng, M., Lao, M., Weng, F., Su, Q.-Y., Zheng, Z.-F., Mei, Y., and Huang, L. (2023). Association of adiposity with risk of obstructive sleep apnea: A population-based study. BMC Public Health, 23.","DOI":"10.1186\/s12889-023-16695-4"},{"key":"ref_23","unstructured":"Ernst, G., Dalzotto, P., Saban, M., Ferraro, F.M., Salvado, A., and Borsini, E.E. (2026, June 04). The Cervical Fat Tissue Volume is a Predictor for Moderate to Severe OSA. Thieme Sleep Science, Available online: https:\/\/www.thieme-connect.de\/products\/ejournals\/abstract\/10.1055\/s-0043-1772827."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1183\/09031936.00183411","article-title":"Sleep apnoea and visceral adiposity in middle-aged male and female subjects","volume":"41","author":"Kritikou","year":"2013","journal-title":"Eur. Respir. J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.sleep.2024.12.021","article-title":"Sleep apnea endotypes and their implications for clinical practise","volume":"126","author":"Edwards","year":"2025","journal-title":"Sleep Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/MCP.0000000000000724","article-title":"Endotypes and phenotypes in obstructive sleep apnea","volume":"26","author":"Malhotra","year":"2020","journal-title":"Curr. Opin. Pulm. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1513\/AnnalsATS.202402-171OC","article-title":"Phenotyping Using Polysomnography Attributes Reduced Respiratory Events after Continuous Positive Airway Pressure Therapy to Improved Upper Airway Collapsibility","volume":"22","author":"Tolbert","year":"2025","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Taranto-Montemurro, L., Messineo, L., and Wellman, A. (2019). Targeting Endotypic Traits with Medications for the Pharmacological Treatment of Obstructive Sleep Apnea. A Review of the Current Literature. J. Clin. Med., 8.","DOI":"10.3390\/jcm8111846"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/thorax-2025-223409","article-title":"Targeting OSA endotypes with drug therapy: Dream or reality?","volume":"80","author":"Cistulli","year":"2025","journal-title":"Thorax"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1056\/NEJMoa2404881","article-title":"Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity","volume":"391","author":"Malhotra","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.chest.2026.02.003","article-title":"The Impact of Weight Loss on the Physiological Endotypes Associated with OSA","volume":"170","author":"Beatty","year":"2026","journal-title":"Chest"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Hsu, Y., Cheng, W.J., Finnsson, E., \u00c1g\u00fastsson, J.S., and Hang, L.W. (2026). Endotypic trait responses to 12-month tirzepatide treatment for an obese patient with obstructive sleep apnea: A case report. Obes. Facts, 1\u201311.","DOI":"10.1159\/000553125"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.5665\/sleep.5762","article-title":"Localizing Effects of Leptin on Upper Airway and Respiratory Control during Sleep","volume":"39","author":"Yao","year":"2016","journal-title":"Sleep"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1152\/japplphysiol.01222.2011","article-title":"Effects of leptin and obesity on the upper airway function","volume":"112","author":"Polotsky","year":"2012","journal-title":"J. Appl. Physiol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Kazemeini, E., Van de Perck, E., Dieltjens, M., Willemen, M., Verbraecken, J., Op de Beeck, S., and Vanderveken, O.M. (2022). Critical to Know Pcrit: A Review on Pharyngeal Critical Closing Pressure in Obstructive Sleep Apnea. Front Neurol., 13.","DOI":"10.3389\/fneur.2022.775709"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"107820","DOI":"10.1016\/j.rmed.2024.107820","article-title":"Deciphering loop gain complexity: A primer for understanding a pathophysiological trait of obstructive sleep apnea patients","volume":"234","author":"Antonaglia","year":"2024","journal-title":"Respir. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1152\/japplphysiol.00972.2010","article-title":"A method for measuring and modeling the physiological traits causing obstructive sleep apnea","volume":"110","author":"Wellman","year":"2011","journal-title":"J. Appl. Physiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.beem.2010.08.001","article-title":"Obstructive sleep apnea and metabolic dysfunction in polycystic ovary syndrome","volume":"24","author":"Nitsche","year":"2010","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.5665\/SLEEP.1162","article-title":"Response of genioglossus muscle to increasing chemical drive in sleeping obstructive apnea patients","volume":"34","author":"Loewen","year":"2011","journal-title":"Sleep"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1161\/CIRCRESAHA.125.325676","article-title":"Obstructive Sleep Apnea and Cardiometabolic Disease: Obesity, Hypertension, and Diabetes","volume":"137","author":"Tasali","year":"2025","journal-title":"Circ. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"101470","DOI":"10.1016\/j.smrv.2021.101470","article-title":"Association between autonomic function and obstructive sleep apnea: A systematic review","volume":"57","author":"Dissanayake","year":"2021","journal-title":"Sleep Med. Rev."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"00126","DOI":"10.1183\/23120541.00126-2022","article-title":"Current and novel treatment options for obstructive sleep apnoea","volume":"8","author":"Randerath","year":"2022","journal-title":"ERJ Open Res."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Redondo, J., Ascher, K.B., and Abreu, A.R. (2026). Redefining Obstructive Sleep Apnea: Treatment in the Modern Era. Pathophysiol. Off. J. Int. Soc. Pathophysiol., 33.","DOI":"10.3390\/pathophysiology33010020"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e13418","DOI":"10.1111\/jsr.13418","article-title":"Metabolic dysfunction in OSA: Is there something new under the sun?","volume":"31","author":"Almendros","year":"2022","journal-title":"J. Sleep Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/cen.14685","article-title":"Endocrine disorders in obstructive sleep apnoea syndrome: A bidirectional relationship","volume":"98","author":"Akset","year":"2023","journal-title":"Clin. Endocrinol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1601731","DOI":"10.1183\/13993003.01731-2016","article-title":"Intermittent hypoxia in obstructive sleep apnoea mediates insulin resistance through adipose tissue inflammation","volume":"49","author":"Murphy","year":"2017","journal-title":"Eur. Respir. J."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.beem.2010.08.011","article-title":"Metabolic consequences of intermittent hypoxia: Relevance to obstructive sleep apnea","volume":"24","author":"Drager","year":"2010","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"231","DOI":"10.31083\/j.rcm2506231","article-title":"Hypoxia-Induced Insulin Resistance Mediates the Elevated Cardiovascular Risk in Patients with Obstructive Sleep Apnea: A Comprehensive Review","volume":"25","year":"2024","journal-title":"Rev. Cardiovasc. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/47254","article-title":"Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension","volume":"402","author":"Barroso","year":"1999","journal-title":"Nature"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Ota, H., Fujita, Y., Yamauchi, M., Muro, S., Kimura, H., and Takasawa, S. (2019). Relationship Between Intermittent Hypoxia and Type 2 Diabetes in Sleep Apnea Syndrome. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20194756"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Shobatake, R., Ota, H., Takahashi, N., Ueno, S., Sugie, K., and Takasawa, S. (2022). Anorexigenic Effects of Intermittent Hypoxia on the Gut\u2014Brain Axis in Sleep Apnea Syndrome. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23010364"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Heffernan, A., Duplancic, D., Kumric, M., Ticinovic Kurir, T., and Bozic, J. (2024). Metabolic Crossroads: Unveiling the Complex Interactions between Obstructive Sleep Apnoea and Metabolic Syndrome. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25063243"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1113\/JP276900","article-title":"Leptin acts in the carotid bodies to increase minute ventilation during wakefulness and sleep and augment the hypoxic ventilatory response","volume":"597","author":"Shin","year":"2019","journal-title":"J. Physiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"113512","DOI":"10.1016\/j.celrep.2023.113512","article-title":"Leptin signaling in the dorsomedial hypothalamus couples breathing and metabolism in obesity","volume":"42","author":"Amorim","year":"2023","journal-title":"Cell Rep."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jacc.2013.05.045","article-title":"Obstructive sleep apnea: A cardiometabolic risk in obesity and the metabolic syndrome","volume":"62","author":"Drager","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"zsac153","DOI":"10.1093\/sleep\/zsac153","article-title":"Leptin-mediated neural targets in obesity hypoventilation syndrome","volume":"45","author":"Amorim","year":"2022","journal-title":"Sleep"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Chang, Z., Ballou, E., Jiao, W., McKenna, K.E., Morrison, S.F., and McCrimmon, D.R. (2013). Systemic leptin produces a long-lasting increase in respiratory motor output in rats. Front. Physiol., 4.","DOI":"10.3389\/fphys.2013.00016"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"bqaf125","DOI":"10.1210\/endocr\/bqaf125","article-title":"Glucagon-Like Peptide 1 (GLP-1) Action on Hypothalamic Feeding Circuits","volume":"166","author":"Hwang","year":"2025","journal-title":"Endocrinology"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00424-012-1111-1","article-title":"Central leptin replacement enhances chemorespiratory responses in leptin-deficient mice independent of changes in body weight","volume":"464","author":"Bassi","year":"2012","journal-title":"Pflug. Arch."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Iglesias, P. (2025). Endocrinology and the Lung: Exploring the Bidirectional Axis and Future Directions. J. Clin. Med., 14.","DOI":"10.3390\/jcm14196985"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/ijo.2014.177","article-title":"Treatment with a GLP-1 receptor agonist diminishes the decrease in free plasma leptin during maintenance of weight loss","volume":"39","author":"Iepsen","year":"2015","journal-title":"Int. J. Obes."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Protasiewicz-Timofticiuc, D.C., B\u0103descu, D., Mo\u021ba, M., \u0218tefan, A.G., Mitrea, A., Clenciu, D., Efrem, I.C., Ro\u0219u, M.M., Vladu, B.E., and Gheonea, T.C. (2024). Back to Roots: Dysbiosis, Obesity, Metabolic Syndrome, Type 2 Diabetes Mellitus, and Obstructive Sleep Apnea\u2014Is There an Objective Connection? A Narrative Review. Nutrients, 16.","DOI":"10.3390\/nu16234057"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"e196346","DOI":"10.1172\/JCI196346","article-title":"Mechanisms and clinical implications of gut-brain interactions","volume":"136","author":"Lorsch","year":"2026","journal-title":"J. Clin. Investig."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1515\/hmbci-2013-0066","article-title":"Sleep disturbances, body fat distribution, food intake and\/or energy expenditure: Pathophysiological aspects","volume":"17","author":"Shechter","year":"2014","journal-title":"Horm. Mol. Biol. Clin. Investig."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"104014","DOI":"10.1016\/j.numecd.2025.104014","article-title":"Obesity and sleep disorders: A bidirectional relationship","volume":"35","author":"Figorilli","year":"2025","journal-title":"Nutr. Metab. Cardiovasc. Dis. NMCD"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1507\/endocrj.K10E-077","article-title":"The role of gut hormones and the hypothalamus in appetite regulation","volume":"57","author":"Suzuki","year":"2010","journal-title":"Endocr. J."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1164\/rccm.200405-579OC","article-title":"Neuropeptide Y and leptin in patients with obstructive sleep apnea syndrome: Role of obesity","volume":"171","author":"Llompart","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1210\/endrev\/bnaa032","article-title":"Revisiting the Complexity of GLP-1 Action from Sites of Synthesis to Receptor Activation","volume":"42","author":"McLean","year":"2021","journal-title":"Endocr. Rev."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Jani\u0107, M., \u0160krgat, S., Harlander, M., Lunder, M., Jane\u017e, A., Pantea Stoian, A., El-Tanani, M., Maggio, V., and Rizzo, M. (2024). Potential Use of GLP-1 and GIP\/GLP-1 Receptor Agonists for Respiratory Disorders: Where Are We at?. Medicina, 60.","DOI":"10.3390\/medicina60122030"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2337\/diabetes.53.1.5","article-title":"Epac: A new cAMP-binding protein in support of glucagon-like peptide-1 receptor-mediated signal transduction in the pancreatic beta-cell","volume":"53","author":"Holz","year":"2004","journal-title":"Diabetes"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1111\/dom.70551","article-title":"The GLP-1-miRNA network: Epigenetic control of obesity and metabolic disorders","volume":"28","author":"Zhao","year":"2026","journal-title":"Diabetes Obes. Metab."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1111\/dom.15083","article-title":"Control of human pancreatic beta cell kinome by glucagon-like peptide-1 receptor biased agonism","volume":"25","author":"Xiao","year":"2023","journal-title":"Diabetes Obes. Metab."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Zhao, X., Wang, M., Wen, Z., Lu, Z., Cui, L., Fu, C., Xue, H., Liu, Y., and Zhang, Y. (2021). GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects. Front. Endocrinol., 12.","DOI":"10.3389\/fendo.2021.721135"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1210\/en.2013-1934","article-title":"GLP-1 receptor localization in monkey and human tissue: Novel distribution revealed with extensively validated monoclonal antibody","volume":"155","author":"Pyke","year":"2014","journal-title":"Endocrinology"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/dom.14496","article-title":"The evolving story of incretins (GIP and GLP-1) in metabolic and cardiovascular disease: A pathophysiological update","volume":"23","author":"Nauck","year":"2021","journal-title":"Diabetes Obes. Metab."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/obr.12465","article-title":"Harnessing glucagon-like peptide-1 receptor agonists for the pharmacological treatment of overweight and obesity","volume":"18","author":"Burcelin","year":"2017","journal-title":"Obes. Rev. Off. J. Int. Assoc. Study Obes."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/apha.12604","article-title":"Mechanisms for the cardiovascular effects of glucagon-like peptide-1","volume":"216","author":"Poudyal","year":"2016","journal-title":"Acta Physiol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.cmet.2023.11.009","article-title":"Central glucagon-like peptide 1 receptor activation inhibits Toll-like receptor agonist-induced inflammation","volume":"36","author":"Wong","year":"2024","journal-title":"Cell Metab."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/cvr\/cvz323","article-title":"Cardiovascular effects of glucagon-like peptide 1 receptor agonists: From mechanistic studies in humans to clinical outcomes","volume":"116","author":"Heuvelman","year":"2020","journal-title":"Cardiovasc. Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"170342","DOI":"10.1016\/j.peptides.2020.170342","article-title":"Intestinal glucagon-like peptide-1 effects on food intake: Physiological relevance and emerging mechanisms","volume":"131","author":"Krieger","year":"2020","journal-title":"Peptides"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1056\/NEJMra2500106","article-title":"GLP-1 Receptor Agonists","volume":"394","author":"Rosen","year":"2026","journal-title":"N. Engl. J. Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12986-016-0153-3","article-title":"Nutritional modulation of endogenous glucagon-like peptide-1 secretion: A review","volume":"13","author":"Bodnaruc","year":"2016","journal-title":"Nutr. Metab."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.ajcnut.2025.04.023","article-title":"Nutritional priorities to support GLP-1 therapy for obesity: A joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society","volume":"122","author":"Mozaffarian","year":"2025","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.amjmed.2025.01.021","article-title":"Mechanisms of GLP-1 Receptor Agonist-Induced Weight Loss: A Review of Central and Peripheral Pathways in Appetite and Energy Regulation","volume":"138","author":"Moiz","year":"2025","journal-title":"Am. J. Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1523\/JNEUROSCI.6326-11.2012","article-title":"The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: A new role for mesolimbic GLP-1 receptors","volume":"32","author":"Dickson","year":"2012","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"bqae155","DOI":"10.1210\/endocr\/bqae155","article-title":"Physiology and Pharmacology of Effects of GLP-1-based Therapies on Gastric, Biliary and Intestinal Motility","volume":"166","author":"Jalleh","year":"2024","journal-title":"Endocrinology"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3945\/jn.114.206029","article-title":"Glucagon-like peptide 1 interacts with ghrelin and leptin to regulate glucose metabolism and food intake through vagal afferent neuron signaling","volume":"145","author":"Ronveaux","year":"2015","journal-title":"J. Nutr."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/j.2040-4603.2020.tb00123.x","article-title":"Glucagon-like Peptide-1: Actions and Influence on Pancreatic Hormone Function","volume":"10","author":"Davis","year":"2020","journal-title":"Compr. Physiol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"e13852","DOI":"10.14814\/phy2.13852","article-title":"GLP-1 suppresses glucagon secretion in human pancreatic alpha-cells by inhibition of P\/Q-type Ca2+ channels","volume":"6","author":"Ramracheya","year":"2018","journal-title":"Physiol. Rep."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Ma, B., Li, Y., Wang, X., Du, L., Wang, S., Ma, H., Zhou, D., Usman, T., Lu, L., and Qu, S. (2022). Association Between Abdominal Adipose Tissue Distribution and Obstructive Sleep Apnea in Chinese Obese Patients. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.847324"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1007\/s11695-019-03870-z","article-title":"Abdominal Obesity Is More Strongly Correlated with Obstructive Sleep Apnea than General Obesity in China: Results from Two Separated Observational and Longitudinal Studies","volume":"29","author":"Zhao","year":"2019","journal-title":"Obes. Surg."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/jdi.13775","article-title":"Effect of glucagon-like peptide-1 receptor agonists on fat distribution in patients with type\u20092 diabetes: A systematic review and meta-analysis","volume":"13","author":"Duan","year":"2022","journal-title":"J. Diabetes Investig."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1530\/JOE-18-0374","article-title":"The key role of a glucagon-like peptide-1 receptor agonist in body fat redistribution","volume":"240","author":"Zhao","year":"2019","journal-title":"J. Endocrinol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2337\/dc24-1678","article-title":"Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference for Patients with Obesity or Overweight: A Systematic Review, Meta-analysis, and Meta-regression of 47 Randomized Controlled Trials","volume":"48","author":"Wong","year":"2025","journal-title":"Diabetes Care"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"108935","DOI":"10.1016\/j.diabres.2021.108935","article-title":"Semaglutide reduces fat accumulation in the tongue: A randomized single-blind, pilot study","volume":"178","author":"Jensterle","year":"2021","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"e13574","DOI":"10.1111\/obr.13574","article-title":"GLP-1 analogs and regional adiposity: A systematic review and meta-analysis","volume":"24","author":"Akoumianakis","year":"2023","journal-title":"Obes. Rev. Off. J. Int. Assoc. Study Obes."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1530\/EC-20-0294","article-title":"Liraglutide protects against high-fat diet-induced kidney injury by ameliorating apoptosis","volume":"9","author":"Liang","year":"2020","journal-title":"Endocr. Connect."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1111\/apt.16608","article-title":"Randomised clinical trial: Semaglutide versus placebo reduced liver steatosis but not liver stiffness in subjects with non-alcoholic fatty liver disease assessed by magnetic resonance imaging","volume":"54","author":"Flint","year":"2021","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/nutrit\/nuaf115","article-title":"Efficacy of Glucagon-Like Peptide-1 Receptor Agonists in Obese or Diabetic Patients With Obstructive Sleep Apnea Syndrome: A Meta-Analysis","volume":"84","author":"Xu","year":"2026","journal-title":"Nutr. Rev."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1097\/HEP.0000000000001608","article-title":"Semaglutide therapy for metabolic dysfunction\u2013associated steatohepatitis: November 2025 updates to AASLD Practice Guidance","volume":"83","author":"Bansal","year":"2026","journal-title":"Hepatology"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1016\/j.jacc.2020.02.056","article-title":"Diabetic Agents, From Metformin to SGLT2 Inhibitors and GLP1 Receptor Agonists: JACC Focus Seminar","volume":"75","author":"Wilcox","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"102782","DOI":"10.1016\/j.eclinm.2024.102782","article-title":"GLP-1 single, dual, and triple receptor agonists for treating type 2 diabetes and obesity: A narrative review","volume":"75","author":"Alfaris","year":"2024","journal-title":"EClinicalMedicine"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/MOL.0000000000000750","article-title":"Lipid effects of glucagon-like peptide 1 receptor analogs","volume":"32","author":"Berberich","year":"2021","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1016\/j.jacc.2018.07.071","article-title":"The Changing Landscape of Diabetes Therapy for Cardiovascular Risk Reduction: JACC State-of-the-Art Review","volume":"72","author":"Newman","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s00125-016-3896-5","article-title":"GLP-1 receptor agonist promotes brown remodelling in mouse white adipose tissue through SIRT1","volume":"59","author":"Xu","year":"2016","journal-title":"Diabetologia"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/cbf.3751","article-title":"Semaglutide (GLP-1 receptor agonist) stimulates browning on subcutaneous fat adipocytes and mitigates inflammation and endoplasmic reticulum stress in visceral fat adipocytes of obese mice","volume":"40","author":"Martins","year":"2022","journal-title":"Cell Biochem. Funct."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"6421","DOI":"10.1074\/jbc.M111.310342","article-title":"Regulation of adipocyte formation by GLP-1\/GLP-1R signaling","volume":"287","author":"Challa","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"106320","DOI":"10.1016\/j.phrs.2022.106320","article-title":"The anti-inflammatory and immunological properties of GLP-1 Receptor Agonists","volume":"182","author":"Bendotti","year":"2022","journal-title":"Pharmacol. Res."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"101737","DOI":"10.1016\/j.eclinm.2022.101737","article-title":"Effects of once-weekly semaglutide 2.4 mg on C-reactive protein in adults with overweight or obesity (STEP 1, 2, and 3): Exploratory analyses of three randomised, double-blind, placebo-controlled, phase 3 trials","volume":"55","author":"Verma","year":"2023","journal-title":"eClinicalMedicine"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1007\/s00125-009-1643-x","article-title":"Glucagon-like peptide-1 receptor signalling selectively regulates murine lymphocyte proliferation and maintenance of peripheral regulatory T cells","volume":"53","author":"Hadjiyanni","year":"2010","journal-title":"Diabetologia"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"e194751","DOI":"10.1172\/JCI194751","article-title":"Antiinflammatory actions of glucagon-like peptide-1\u2013based therapies beyond metabolic benefits","volume":"135","author":"Wong","year":"2025","journal-title":"J. Clin. Investig."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.cmet.2024.05.001","article-title":"Glucagon-like peptide 1 receptor is a T cell-negative costimulatory molecule","volume":"36","author":"Usuelli","year":"2024","journal-title":"Cell Metab."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"3094642","DOI":"10.1155\/2016\/3094642","article-title":"Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control","volume":"2016","author":"Lee","year":"2016","journal-title":"Mediat. Inflamm."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1210\/jc.2011-1508","article-title":"Exenatide exerts a potent antiinflammatory effect","volume":"97","author":"Chaudhuri","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"152822","DOI":"10.1016\/j.bbrc.2025.152822","article-title":"GLP-1 receptor agonists and inflammatory pathway modulation: Dual targeting of metabolic and immune dysfunction in insulin resistance","volume":"789","author":"Ngabea","year":"2025","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3727\/096368911X576027","article-title":"Anti-Inflammatory Properties of Exenatide in Human Pancreatic Islets","volume":"21","author":"Cechin","year":"2012","journal-title":"Cell Transplant."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/ijo.2016.52","article-title":"Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: The SCALE Sleep Apnea randomized clinical trial","volume":"40","author":"Blackman","year":"2016","journal-title":"Int. J. Obes."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1513\/AnnalsATS.202309-821OC","article-title":"Continuous Positive Airway Pressure But Not GLP1-Mediated Weight Loss Improves Early Cardiovascular Disease in Obstructive Sleep Apnea: A Randomized Proof-of-Concept Study","volume":"21","author":"Crilly","year":"2024","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1007\/s11325-022-02768-y","article-title":"Efficacy and safety of liraglutide in patients with type 2 diabetes mellitus and severe obstructive sleep apnea","volume":"27","author":"Jiang","year":"2023","journal-title":"Sleep Breath. Schlaf. Atm."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"zsae280","DOI":"10.1093\/sleep\/zsae280","article-title":"Glucagon-like peptide-1 receptor agonists for the treatment of obstructive sleep apnea: A meta-analysis","volume":"48","author":"Li","year":"2025","journal-title":"Sleep"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1002\/oby.24126","article-title":"GLP-1 therapy increases visceral adipose tissue metabolic activity: Lessons from a randomized controlled trial in obstructive sleep apnea","volume":"32","author":"Ryan","year":"2024","journal-title":"Obesity"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"e70152","DOI":"10.1111\/jsr.70152","article-title":"Effect of Liraglutide on Intermittent Hypoxia-Induced Metabolic Dysfunction: From Bench to Bedside","volume":"35","author":"King","year":"2026","journal-title":"J. Sleep Res."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.bbrc.2020.06.054","article-title":"(EX-4)2-Fc, an effective long-acting GLP-1 receptor agonist, reduces obesity-related inflammation by inhibiting leptin expression","volume":"529","author":"Zhou","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1530\/JOE-18-0639","article-title":"Exenatide mitigates inflammation and hypoxia along with improved angiogenesis in obese fat tissue","volume":"242","author":"Xian","year":"2019","journal-title":"J. Endocrinol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1007\/s00125-012-2592-3","article-title":"Glucagon-like peptide-1 inhibits adipose tissue macrophage infiltration and inflammation in an obese mouse model of diabetes","volume":"55","author":"Lee","year":"2012","journal-title":"Diabetologia"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1111\/bph.13481","article-title":"Effects of glucagon-like peptide-1 on the differentiation and metabolism of human adipocytes","volume":"173","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"106121","DOI":"10.1016\/j.ebiom.2026.106121","article-title":"Generation and characterisation of a humanised GLP-1 receptor mouse model for translational drug development","volume":"124","author":"Sonne","year":"2026","journal-title":"eBioMedicine"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1038\/oby.2011.50","article-title":"Comparative Effects of the Long-Acting GLP-1 Receptor Ligands, Liraglutide and Exendin-4, on Food Intake and Body Weight Suppression in Rats","volume":"19","author":"Hayes","year":"2011","journal-title":"Obesity"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1172\/JCI75276","article-title":"The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss","volume":"124","author":"Secher","year":"2014","journal-title":"J. Clin. Investig."},{"key":"ref_131","first-page":"zsw074","article-title":"Prolonged Exposures to Intermittent Hypoxia Promote Visceral White Adipose Tissue Inflammation in a Murine Model of Severe Sleep Apnea: Effect of Normoxic Recovery","volume":"40","author":"Almendros","year":"2017","journal-title":"Sleep"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"149882","DOI":"10.1016\/j.bbrc.2024.149882","article-title":"Semaglutide alters gut microbiota and improves NAFLD in db\/db mice","volume":"710","author":"Mao","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"15582","DOI":"10.1038\/s41598-019-52103-x","article-title":"Metabolic and gut microbiome changes following GLP-1 or dual GLP-1\/GLP-2 receptor agonist treatment in diet-induced obese mice","volume":"9","author":"Madsen","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"106719","DOI":"10.1016\/j.sleep.2025.106719","article-title":"Effect of tirzepatide treatment on patient-reported outcomes among SURMOUNT-OSA participants with obstructive sleep apnea and obesity","volume":"134","author":"Kanu","year":"2025","journal-title":"Sleep Med."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1186\/s12967-025-06302-y","article-title":"Glucagon-like Peptide-1 receptor agonists for obstructive sleep apnea in patients with obesity and type 2 diabetes mellitus: A systematic review and meta-analysis","volume":"23","author":"Yang","year":"2025","journal-title":"J. Transl. Med."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.sleep.2025.02.010","article-title":"Efficacy and safety of GLP-1 receptor agonists in the management of obstructive sleep apnea in individuals without diabetes: A systematic review and meta-analysis of randomized, placebo-controlled trials","volume":"129","author":"Kow","year":"2025","journal-title":"Sleep Med."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"2484048","DOI":"10.1080\/20018525.2025.2484048","article-title":"Safety and efficacy of glucagon-like peptide-1 receptor agonists in patients with obstructive sleep apnea: A systematic review and meta-analysis of randomized controlled trials","volume":"12","author":"Altobaishat","year":"2025","journal-title":"Eur. Clin. Respir. J."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"102119","DOI":"10.1016\/j.smrv.2025.102119","article-title":"Efficacy of incretin-based therapies in obesity-related obstructive sleep apnea: A systematic review and meta-analysis of randomized controlled trials","volume":"82","author":"Matics","year":"2025","journal-title":"Sleep Med. Rev."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"e45445","DOI":"10.1097\/MD.0000000000045445","article-title":"Tirzepatide-induced weight loss and obstructive sleep apnea improvement in an adult with type 2 diabetes: A case report","volume":"104","author":"Funamizu","year":"2025","journal-title":"Medicine"},{"key":"ref_140","first-page":"773","article-title":"Clinical Practice Guideline for the Treatment of Obstructive Sleep Apnea and Snoring with Oral Appliance Therapy: An Update for 2015","volume":"11","author":"Ramar","year":"2015","journal-title":"J. Clin. Sleep Med. JCSM Off. Publ. Am. Acad. Sleep Med."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1097\/MLG.0b013e31816422ea","article-title":"The efficacy of multilevel surgery of the upper airway in adults with obstructive sleep apnea\/hypopnea syndrome","volume":"118","author":"Lin","year":"2008","journal-title":"Laryngoscope"},{"key":"ref_142","first-page":"86","article-title":"Effects of liraglutide on sleep-disordered breathing and diabetic microangiopathy in patients with type 2 diabetes mellitus and obstructive sleep apnea-hypopnea syndrome","volume":"12","author":"Liu","year":"2020","journal-title":"Chin. J. Diabetes Mellit."},{"key":"ref_143","first-page":"335","article-title":"Treatment of Adult Obstructive Sleep Apnea with Positive Airway Pressure: An American Academy of Sleep Medicine Clinical Practice Guideline","volume":"15","author":"Patil","year":"2019","journal-title":"J. Clin. Sleep Med. JCSM Off. Publ. Am. Acad. Sleep Med."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"e038856","DOI":"10.1136\/bmjopen-2020-038856","article-title":"Randomised, cOntrolled Multicentre trial of 26 weeks subcutaneous liraglutide (a glucagon-like peptide-1 receptor Agonist), with or without contiNuous positive airway pressure (CPAP), in patients with type 2 diabetes mellitus (T2DM) and obstructive sleep apnoEa (OSA) (ROMANCE): Study protocol assessing the effects of weight loss on the apnea-hypnoea index (AHI)","volume":"10","author":"Sprung","year":"2020","journal-title":"BMJ Open"},{"key":"ref_145","unstructured":"US Food and Drug Administration (2026, July 28). FDA Approves First Medication for Obstructive Sleep Apnea, Available online: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-medication-obstructive-sleep-apnea."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide Once Weekly for the Treatment of Obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-Weekly Semaglutide in Adults with Overweight or Obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_148","first-page":"CD015092","article-title":"Semaglutide for adults living with obesity","volume":"10","author":"Bracchiglione","year":"2025","journal-title":"Cochrane Database Syst. Rev."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/16\/7108\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T09:28:59Z","timestamp":1786354139000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/16\/7108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,8]]},"references-count":148,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["ijms27167108"],"URL":"https:\/\/doi.org\/10.3390\/ijms27167108","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,8]]}}}